Gábor Répássy

Zalutumumab plus best supportive care versus best supportive care alone in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck after failure of platinum-based chemotherapy: an open-label, randomised phase 3 trial

Jean-Pascal Machiels, Somasundaram Subramanian, Ágnes Ruzsa et al. · The Lancet Oncology · 2011 · 240 citations

Neoadjuvant Therapy, Medicine, Randomised Phase 3 +9

Neoadjuvant Immunotherapy of Oral Squamous Cell Carcinoma Modulates Intratumoral CD4/CD8 Ratio and Tumor Microenvironment: A Multicenter Phase II Clinical Trial

Andrea Ladányi, Csaba Forster‐Horváth, Júlia Lukits et al. · Journal of Clinical Oncology · 2005 · 58 citations · Full text

The Pathogenesis of Nasal Polyposis by Immunoglobulin E and Interleukin‐5 Is Completed by Transforming Growth Factor‐β1

Andor Hirschberg, Adrienn Jókúti, Zsuzsa Darvas et al. · The Laryngoscope · 2003 · 48 citations

Efficacy and tolerability of a fixed low-dose combination of cinnarizine and dimenhydrinate in the treatment of vertigo: A 4-week, randomized, double-blind, active- and placebo-controlled, parallel-group, outpatient study

J. Pytel, György M. Nagy, Ágnes Tóth et al. · Clinical Therapeutics · 2007 · 46 citations

Balance Disorders, Medicine, Neuropharmacology +6

Correlations Between Prognosis and Regional Biomarker Profiles in Head and Neck Squamous Cell Carcinomas

Gabriella Szentkúti, Kornél Dános, Diána Brauswetter et al. · Pathology & Oncology Research · 2014 · 36 citations

Regional Biomarker Profiles, Prognostic Biomarkers, Correlations Between Prognosis +9